ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 123 filers reported holding ROYALTY PHARMA PLC in Q2 2020. The put-call ratio across all filers is 0.58 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,168,732 | -2.6% | 2,438,052 | +10.4% | 0.02% | +4.8% |
| Q2 2023 | $67,901,176 | +26.9% | 2,208,887 | +48.7% | 0.02% | +16.7% |
| Q1 2023 | $53,520,274 | -2.4% | 1,485,436 | +7.1% | 0.02% | -5.3% |
| Q4 2022 | $54,820,000 | -0.7% | 1,387,148 | +0.9% | 0.02% | -5.0% |
| Q3 2022 | $55,216,000 | +1.8% | 1,374,241 | +6.6% | 0.02% | +5.3% |
| Q2 2022 | $54,220,000 | +7.7% | 1,289,699 | -0.2% | 0.02% | +26.7% |
| Q1 2022 | $50,331,000 | -2.9% | 1,292,117 | -0.7% | 0.02% | +7.1% |
| Q4 2021 | $51,819,000 | +11.0% | 1,300,671 | +0.7% | 0.01% | -6.7% |
| Q3 2021 | $46,702,000 | -15.7% | 1,292,261 | -4.4% | 0.02% | -11.8% |
| Q2 2021 | $55,427,000 | +0.5% | 1,352,176 | +7.0% | 0.02% | -5.6% |
| Q1 2021 | $55,153,000 | +39.0% | 1,263,884 | +59.4% | 0.02% | +28.6% |
| Q4 2020 | $39,672,000 | +51.9% | 792,683 | +27.7% | 0.01% | +27.3% |
| Q3 2020 | $26,115,000 | -62.3% | 620,718 | -56.5% | 0.01% | -63.3% |
| Q2 2020 | $69,201,000 | – | 1,425,370 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |